Literature DB >> 1854696

Experimental Acanthamoeba keratitis: II. Immunohistochemical evaluation.

D F Larkin1, D L Easty.   

Abstract

In a Wistar rat experimental model of Acanthamoeba keratitis immunohistochemical techniques were used to analyse the host cellular response. The inflammatory cell profile was observed to change at intervals. In tissue sections the cellular response consisted of neutrophils on the first day but predominantly macrophages on the following days. Some T lymphocytes but no B lymphocytes were observed.

Entities:  

Mesh：

Year:  1991        PMID： 1854696      PMCID： PMC1042410          DOI： 10.1136/bjo.75.7.421

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  14 in total

1.  Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts.

Authors:  D J Paterson; W A Jefferies; J R Green; M R Brandon; P Corthesy; M Puklavec; A F Williams
Journal:  Mol Immunol       Date:  1987-12       Impact factor: 4.407

2.  Ocular immune responses. II. Priming of A/J mice in the vitreous induces either enhancement of or suppression of subsequent hapten-specific DTH responses.

Authors:  C S Foster; J G Monroe; R Campbell; J Kalpaxis; R Wetzig; M I Greene
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

3.  Molecular and antigenic heterogeneity of the rat leukocyte-common antigen from thymocytes and T and B lymphocytes.

Authors:  G R Woollett; A N Barclay; M Puklavec; A F Williams
Journal:  Eur J Immunol       Date:  1985-02       Impact factor: 5.532

Review 4.  Acanthamoeba keratitis. A review of the literature.

Authors:  J D Auran; M B Starr; F A Jakobiec
Journal:  Cornea       Date:  1987       Impact factor: 2.651

5.  Experimental Acanthamoeba keratitis: I. Preliminary findings.

Authors:  D F Larkin; D L Easty
Journal:  Br J Ophthalmol       Date:  1990-09       Impact factor: 4.638

6.  The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3.

Authors:  C D Dijkstra; E A Döpp; P Joling; G Kraal
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

7.  Acanthamoeba keratitis successfully treated medically.

Authors:  P Wright; D Warhurst; B R Jones
Journal:  Br J Ophthalmol       Date:  1985-10       Impact factor: 4.638

8.  Purification of human C3b inactivator by monoclonal-antibody affinity chromatography.

Authors:  L Hsiung; A N Barclay; M R Brandon; E Sim; R R Porter
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

9.  Immunopathology and electron microscopy of Acanthamoeba keratitis.

Authors:  W Mathers; G Stevens; M Rodrigues; C C Chan; J Gold; G S Visvesvara; M A Lemp; L E Zimmerman
Journal:  Am J Ophthalmol       Date:  1987-05-15       Impact factor: 5.258

10.  The epidemiology of Acanthamoeba keratitis in the United States.

Authors:  J K Stehr-Green; T M Bailey; G S Visvesvara
Journal:  Am J Ophthalmol       Date:  1989-04-15       Impact factor: 5.258
View more
  9 in total

Review 1.  The immunobiology of Acanthamoeba keratitis.

Authors:  J Y Niederkorn; H Alizadeh; H F Leher; J P McCulley
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Acanthamoeba Activates Macrophages Predominantly through Toll-Like Receptor 4- and MyD88-Dependent Mechanisms To Induce Interleukin-12 (IL-12) and IL-6.

Authors:  Antonella Cano; Antonella Mattana; Stuart Woods; Fiona L Henriquez; James Alexander; Craig W Roberts
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

3.  Exacerbation of Acanthamoeba keratitis in animals treated with anti-macrophage inflammatory protein 2 or antineutrophil antibodies.

Authors:  M Hurt; S Apte; H Leher; K Howard; J Niederkorn; H Alizadeh
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Role of phospholipase A₂ (PLA₂) inhibitors in attenuating apoptosis of the corneal epithelial cells and mitigation of Acanthamoeba keratitis.

Authors:  Trivendra Tripathi; Mahshid Abdi; Hassan Alizadeh
Journal:  Exp Eye Res       Date:  2013-06-20       Impact factor: 3.467

5.  IL-17A-mediated protection against Acanthamoeba keratitis.

Authors:  Amol Suryawanshi; Zhiyi Cao; James F Sampson; Noorjahan Panjwani
Journal:  J Immunol       Date:  2014-12-10       Impact factor: 5.422

Review 6.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

7.  Clinical and histologic evaluations of experimental Acanthamoeba keratitis.

Authors:  Zubeyde Akin Polat; Semra Ozcelik; Ayse Vural; Esin Yildiz; Ali Cetin
Journal:  Parasitol Res       Date:  2007-08-14       Impact factor: 2.289

8.  Pathogenic strains of Acanthamoeba are recognized by TLR4 and initiated inflammatory responses in the cornea.

Authors:  Hassan Alizadeh; Trivendra Tripathi; Mahshid Abdi; Ashley Dawn Smith
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

9.  Amoebicidal effect of Allium cepa against Allovahlkampfia spelaea: A keratitis model.

Authors:  Hanan E M Eldeek; Haiam Mohamed Mahmoud Farrag; Mohammed Essa Marghany Tolba; Heba E M El-Deek; Marwa Omar Ali; Zedan Z Ibraheim; Soad A L Bayoumi; Ebtisam Shawky Ahmed Hassanin; Samia S Alkhalil; Enas Abd El Hameed Mahmoud Huseein
Journal:  Saudi Pharm J       Date:  2022-06-13       Impact factor: 4.562
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.